RPL19

Large ribosomal subunit protein eL19 · P84098 · RPL19 on Sugi Atlas →

0 patent compounds predicted against RPL19, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to RPL19 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES PHASE3UNKNOWN
Everolimus for Children With Recurrent or Progressive Ependymoma PHASE2COMPLETED
Antiviral Activity and Safety of 3 Different Doses of Mifepristone in Hepatitis C Infected Patients PHASE2COMPLETED
Study of Decitabine in Combination With Sequential Rapamycin or Ribavirin in High Risk AML Patients PHASE1/PHASE2COMPLETED
Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer PHASE2COMPLETED
Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient Diamond-Blackfan Anemia PHASE1RECRUITING
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma PHASE1COMPLETED
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery PHASE1COMPLETED
Safety and Pharmacology of SNX-5422 Plus Carboplatin and Paclitaxel in Subjects With Solid Tumors PHASE1COMPLETED
Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment PHASE1COMPLETED
Study of Oral CNF2024 (BIIB021) in Advanced Solid Tumors PHASE1COMPLETED
Effect of Branched Chain Amino Acids on Muscle nanCOMPLETED
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pathobiology, and a Prospective Non-Randomized Clinical Trial of Hearing Preservation Surgery in Patients With Early Stage Endolymphatic Sac Tumors nanCOMPLETED
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Modulation of Steroid Immunosuppression by Alveolar Efferocytosis nanCOMPLETED
RibOSE - Glucose and Resistance Exercise Training nanCOMPLETED
Genetic Variation in TRAF3IP2 (rs13190932) nanRECRUITING
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Role of Piwi-protein Interacting RNA, miRNA-194 and Amino Acids in Patients With Prostate Cancer nanUNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus nanCOMPLETED
FASHION Fabry Disease Hypertrophic Cardiomyopathy and Infammation nanUNKNOWN
Genetics of Endocrine Tumours - Familial Isolated Pituitary Adenoma - FIPA nanRECRUITING
Perfusion-Induced Hyperthermia for Metastatic Carcinoma nanCOMPLETED
Somatosensory Modulation of Salivary Gene Expression and Oral Feeding in Preterm Infants nanCOMPLETED
Chronic Cough and CANVAS (Cerebellar Ataxia With Neuropathy and Bilateral Vestibular Areflexia Syndrome) nanCOMPLETED
Impact of Mutations in Aminoacyl tRNA Synthetases on Protein Translation and Cellular Stress nanWITHDRAWN
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a RPL19 binder may also engage these)

ProteinNameSimilarity
P84099 1.000 P84099 →
P84100 1.000 P84100 →
Q5RB99 1.000 Q5RB99 →
D0VWQ5 1.000 D0VWQ5 →
Q7ZYS1 1.000 Q7ZYS1 →
Q90YU8 1.000 Q90YU8 →
G1TYL6 1.000 G1TYL6 →
P05734 1.000 P05734 →
Q6P5L3 1.000 Q6P5L3 →
Q9LUQ6 1.000 Q9LUQ6 →
Q3T0W9 1.000 Q3T0W9 →
Q8HXN9 1.000 Q8HXN9 →
P49693 1.000 P49693 →
O02639 1.000 O02639 →
O42699 1.000 O42699 →
P36241 0.999 P36241 →
A0A1D8PK40 0.996 A0A1D8PK40 →
P0CX83 0.993 P0CX83 →
P0DJ60 0.993 P0DJ60 →
Q9SRX2 0.992 Q9SRX2 →
P14329 0.992 P14329 →
Q9UX89 0.991 Q9UX89 →
P0CX82 0.989 P0CX82 →
A5CF22 0.984 A5CF22 →
O49885 0.984 O49885 →
P62299 0.984 P62299 →
P22738 0.984 P22738 →
Q29293 0.984 Q29293 →
Q8SRP1 0.984 Q8SRP1 →
Q601J1 0.983 Q601J1 →